24.04.2024 • NewsKBRSABICFujian

KBR Wins Contract from SABIC Fujian Petrochemicals

US-based multinational contractor KBR has been awarded a contract by SABIC Fujian Petrochemicals to license its phenol technology in China.

Under the terms of the contract, KBR will provide technology licensing and proprietary engineering design for a 250 kt/a phenol plant at SABIC Fujian Petrochemical’s complex in China’s Fujian province. The final investment decision for this estimated $6.4 billion project was announced in January 2024 with expected completion in 2026. According to KBR, its phenol technology offers reduced energy consumption and improved yields.

“We are excited to offer our industry leading phenol technology to SABIC Fujian for this ambitious project in China,” said Jay Ibrahim, president of KBR Sustainable Technology Solutions. “KBR’s market-leading phenol technology increases our customers’ competitive advantage and advances their sustainability objectives through superior efficiency, reliability, wastewater recovery and performance,” Ibrahim added.

© KBR
© KBR

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.